242 related articles for article (PubMed ID: 15510323)
1. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients.
Wong PN; Mak SK; Lo KY; Tong GM; Wong AK
Singapore Med J; 2004 Nov; 45(11):520-4. PubMed ID: 15510323
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
3. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
[TBL] [Abstract][Full Text] [Related]
4. Impact of introduction of continuous ambulatory peritoneal dialysis on blood pressure: analysis of 24-hour ambulatory blood pressure.
Shoda J; Nakamoto H; Okada H; Suzuki H
Adv Perit Dial; 2000; 16():97-101. PubMed ID: 11045270
[TBL] [Abstract][Full Text] [Related]
5. Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.
Malatino LS; Benedetto FA; Mallamaci F; Tripepi G; Zoccali C; Parlongo S; Cutrupi S; Marino C; Panuccio V; Garozzo M; Candela V; Bellanuova I; Cataliotti A; Rapisarda F; Fatuzzo P; Bonanno G; Seminara G; Stancanelli B; Tassone F; Labate C
J Nephrol; 1999; 12(4):256-60. PubMed ID: 10493569
[TBL] [Abstract][Full Text] [Related]
6. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
[TBL] [Abstract][Full Text] [Related]
7. Volume overload in patients treated with continuous ambulatory peritoneal dialysis associated with reduced circadian blood pressure variation.
Yang JH; Cheng LT; Gu Y; Tang LJ; Wang T; Lindholm MB; Axelsson J
Blood Purif; 2008; 26(5):399-403. PubMed ID: 18594139
[TBL] [Abstract][Full Text] [Related]
8. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
9. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with drug adherence and blood pressure control in patients with hypertension.
Morris AB; Li J; Kroenke K; Bruner-England TE; Young JM; Murray MD
Pharmacotherapy; 2006 Apr; 26(4):483-92. PubMed ID: 16553506
[TBL] [Abstract][Full Text] [Related]
11. Residual renal function and volume control in peritoneal dialysis patients.
Cheng LT; Chen W; Tang W; Wang T
Nephron Clin Pract; 2006; 104(1):c47-54. PubMed ID: 16741370
[TBL] [Abstract][Full Text] [Related]
12. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation.
Hüting J; Alpert MA
Clin Cardiol; 1992 Mar; 15(3):190-6. PubMed ID: 1532353
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
14. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study].
Poch E; Martinez X; Rodrigo JA; Tovar JL;
Nefrologia; 2006; 26(5):564-72. PubMed ID: 17117899
[TBL] [Abstract][Full Text] [Related]
15. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad.
Ahmed N; Abdul Khaliq M; Shah SH; Anwar W
J Ayub Med Coll Abbottabad; 2008; 20(2):66-9. PubMed ID: 19385461
[TBL] [Abstract][Full Text] [Related]
16. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.
Rojas-Campos E; Alcántar-Medina M; Cortés-Sanabria L; Martínez-Ramírez HR; Camarena JL; Chávez S; Flores A; Nieves JJ; Monteón F; Gómez-Navarro B; Cueto-Manzano AM
Rev Invest Clin; 2007; 59(3):184-91. PubMed ID: 17910410
[TBL] [Abstract][Full Text] [Related]
17. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients.
Wang X; Axelsson J; Lindholm B; Wang T
Blood Purif; 2005; 23(5):373-8. PubMed ID: 16088105
[TBL] [Abstract][Full Text] [Related]
18. Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin.
Anastassiades E; Howarth D; Howarth J; Shanks D; Waters H; Hyde K; Yin JL; Geary C; Gokal R
Nephrol Dial Transplant; 1993; 8(7):621-5. PubMed ID: 8396746
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
20. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
Muxfeldt ES; Salles GF
J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
